NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/26/2026
Back to search
Official data from USPTO
MYOLARIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MYOLARIS
ST13
US500000097408309Class
10, 42
Filing
97408309
Registration
8274306
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
05/26/2026
Trademark type
Word
Nice classes
10, 42
Filing date
05/12/2022
Registration date
05/26/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2026
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/30/2024
First use in commerce
2025-08-00
Drawing code
4
Owner type
03
Owner location
Framingham, MA, US
Examiner
LEE, CATHERINE ANNE
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Olaris, Inc.
Representatives
Alex P. Garens DAY PITNEY LLP
Technical classification
Nice Classes
Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical diagnostic solutions and platforms for medical and research purposesmedical apparatus for testing the presence of biomarkers relevant for treatment responsiveness and drug efficacy
Class 42
Providing medical and scientific testing information services for medical and scientific research purposesreporting test results and analysis of customers tests; computer aided biomarker discovery services for identifying potential biomarkers for use in researching diseasediagnosis of diseasedrug compound safetydrug efficacytreatment efficacytherapy responsivenessdrug side-effects; providing scientific analysis and informational reports based upon results of laboratory testing in the field of diagnostics and biomarkers; providing online computer databases featuring scientific information based on aggregated results of biomarker testing
Publications
History of USPTO decisions and trademark events.
47 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/04/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/04/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/01/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/01/2026
EX5G
SOU EXTENSION 5 GRANTED
05/01/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/01/2026
IUAF
USE AMENDMENT FILED
12/08/2025
EXT5
SOU EXTENSION 5 FILED
12/08/2025
EISU
TEAS STATEMENT OF USE RECEIVED
12/08/2025
EEXT
SOU TEAS EXTENSION RECEIVED
12/08/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/17/2025
EX4G
SOU EXTENSION 4 GRANTED
05/16/2025
EXT4
SOU EXTENSION 4 FILED
05/16/2025
EEXT
SOU TEAS EXTENSION RECEIVED
05/16/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX3G
SOU EXTENSION 3 GRANTED
12/14/2024
EXT3
SOU EXTENSION 3 FILED
12/13/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/13/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/23/2024
EX2G
SOU EXTENSION 2 GRANTED
05/22/2024
EXT2
SOU EXTENSION 2 FILED
05/22/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/22/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/10/2023
EX1G
SOU EXTENSION 1 GRANTED
11/08/2023
EXT1
SOU EXTENSION 1 FILED
11/08/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/08/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/25/2023
PUBO
PUBLISHED FOR OPPOSITION
04/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/21/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/21/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/21/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/21/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/16/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/14/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/02/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/02/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/02/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/02/2023
DOCK
ASSIGNED TO EXAMINER
03/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/17/2022
NWAP
NEW APPLICATION ENTERED
05/16/2022
Continuous trademark protection
Get notified about every new filing that threatens MYOLARIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.